Relative Efficacy of Pharmacotherapy for Diabetic Peripheral Neuropathy
This systematic review and Bayesian meta-analysis evaluated the relative efficacy of 18 oral pharmacotherapeutic interventions for diabetic peripheral neuropathy.
This systematic review and Bayesian meta-analysis evaluated the relative efficacy of 18 oral pharmacotherapeutic interventions for diabetic peripheral neuropathy.
Patients with hand osteoarthritis or psoriatic arthritis with 100-point visual analogue scale pain scores of ≥30 mm were randomized to receive 10 mg daily oral CBD increased to twice daily after 2 weeks or placebo for 12 weeks.
The use of intravenous acetaminophen as first-line therapy for older adults with polytrauma reduced perioperative opioid use.
Between September and October 2020, a cohort of 1360 current alcohol drinkers were recruited in the United Kingdom using targeted Facebook advertisements.
This cross-sectional geospatial analysis was conducted by investigators at the University of Chicago using the social vulnerability index data from the CDC and data from SAMHSA.
This real-world study examined the link between type 2 diabetes treatment goals and musculoskeletal pain.
Rapid opioid dose reduction or discontinuation exceeding existing pain management guidelines was linked to increased opioid-related harm risk.
This systematic review did not find any high quality evidence supporting the use of injectable biologics for neuropathic pain.
Data for this study were sourced from 4 active treatment arms of 4 randomized, controlled trials conducted by the National Institutes of Health in the United States between 2006 and 2018.
This study evaluated patterns of prehospital pain management utilized by emergency medical services across the United States.